TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial.

Eleftherios P Mamounas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.